CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Class A and Class B common stock	Additional paid-in capital	Accumulated other comprehensive (loss) income	Accumulated deficit
Beginning balance at Dec. 31, 2021	$ 2,175,957	$ 175	$ 7,874,038	$ (47,739)	$ (5,650,517)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options		2	14,996
Equity-based compensation			191,584
Foreign currency translation adjustments, net of tax	(54,717)			(54,717)
Actuarial gain (loss) on defined severance benefits, net of tax	38,250			38,250
Net income (loss)	(194,106)				(194,106)
Ending balance at Sep. 30, 2022	2,171,966	$ 177	8,080,618	(64,206)	(5,844,623)
Beginning balance (in shares) at Dec. 31, 2021		1,754,203
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net issuance of common units, equity-based compensation plan (in shares)		7,382
Issuance of common stock upon settlement of restricted stock units (in shares)		7,358
Ending balance (in shares) at Sep. 30, 2022		1,768,943
Beginning balance at Jun. 30, 2022	2,068,096	$ 177	8,014,912	(11,691)	(5,935,302)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options			2,631
Equity-based compensation			63,075
Foreign currency translation adjustments, net of tax	(52,758)			(52,758)
Actuarial gain (loss) on defined severance benefits, net of tax	243			243
Net income (loss)	90,679				90,679
Ending balance at Sep. 30, 2022	2,171,966	$ 177	8,080,618	(64,206)	(5,844,623)
Beginning balance (in shares) at Jun. 30, 2022		1,765,117
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net issuance of common units, equity-based compensation plan (in shares)		1,204
Issuance of common stock upon settlement of restricted stock units (in shares)		2,622
Ending balance (in shares) at Sep. 30, 2022		1,768,943
Beginning balance at Dec. 31, 2022	2,413,913	$ 177	8,154,076	2,219	(5,742,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options			7,825
Issuance of common stock upon settlement of restricted stock units		2	(1)
Equity-based compensation			240,098
Foreign currency translation adjustments, net of tax	(53,232)			(53,232)
Actuarial gain (loss) on defined severance benefits, net of tax	(7,575)			(7,575)
Net income (loss)	327,347				327,347
Ending balance at Sep. 30, 2023	2,928,377	$ 179	8,401,998	(58,588)	(5,415,212)
Beginning balance (in shares) at Dec. 31, 2022		1,772,607
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net issuance of common units, equity-based compensation plan (in shares)		3,511
Issuance of common stock upon settlement of restricted stock units (in shares)		9,769
Ending balance (in shares) at Sep. 30, 2023		1,785,887
Beginning balance at Jun. 30, 2023	2,775,477	$ 178	8,316,100	(34,289)	(5,506,512)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options			2,104
Issuance of common stock upon settlement of restricted stock units		1	(1)
Equity-based compensation			83,795
Foreign currency translation adjustments, net of tax	(25,552)			(25,552)
Actuarial gain (loss) on defined severance benefits, net of tax	1,253			1,253
Net income (loss)	91,300				91,300
Ending balance at Sep. 30, 2023	$ 2,928,377	$ 179	$ 8,401,998	$ (58,588)	$ (5,415,212)
Beginning balance (in shares) at Jun. 30, 2023		1,781,269
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net issuance of common units, equity-based compensation plan (in shares)		914
Issuance of common stock upon settlement of restricted stock units (in shares)		3,704
Ending balance (in shares) at Sep. 30, 2023		1,785,887